About Careers MedBlog Contact us
Injecting Nanocarriers may Release Drugs in The Body for Months

Injecting Nanocarriers may Release Drugs in The Body for Months

Font : A-A+

  • Nanocarriers that can deliver and release drugs into the body for months have been developed.
  • This drug delivery act as a drug depot inside the body.
  • It then slowly breaks down into spherical nanomaterials to provide continuous release of drugs for months.

A nanocarrier formulation that forms into a gel inside the body at the site of injection and then continuously releases drugs through nanoscale drug-loaded vehicles for months inside the body, according to research at the Northwestern University.

Nanometer-scale vehicles called nanocarriers can deliver higher concentrations of drugs to bombard specific areas of the body while minimizing systemic side effects. Nanocarriers can also deliver drugs and diagnostic agents that are typically not soluble in water or blood as well as significantly decrease the effective dosage.


Injecting Nanocarriers may Release Drugs in The Body for Months

Although this method might seem ideal for treating diseases, nanocarriers are not without their challenges.

Continuous delivery of drugs without harming the body
"Controlled, sustained delivery is advantageous for treating many chronic disorders, but this is difficult to achieve with nanomaterials without inducing undesirable local inflammation," said Northwestern University's Evan Scott. "Instead, nanomaterials are typically administered as multiple separate injections or as a transfusion that can take longer than an hour. It would be great if physicians could give one injection, which continuously released nanomaterials over a controlled period of time."

Now Scott, an assistant professor of biomedical engineering in Northwestern's McCormick School of Engineering, has developed a new mechanism that makes that controlled, sustained delivery possible.

Scott's team designed a nanocarrier formulation that, after quickly forming into a gel inside the body at the site of injection, can continuously release nanoscale drug-loaded vehicles for months. The gel itself re-assembles into the nanocarriers, so after all of the drug has been delivered, no residual material is left to induce inflammation or fibrous tissue formation. This system could, for example, enable single-administration vaccines that do not require boosters as well as a new way to deliver chemotherapy, hormone therapy, or drugs that facilitate wound healing.

Avoiding possible side-effects of nanocarriers
Currently, the most common sustained nanocarrier delivery systems hold nanomaterials within polymer matrices. These networks are implanted into the body, where they slowly release the trapped drug carriers over a period of time. The problem lies after the delivery is complete: the networks remain inside the body, often eliciting a foreign-body response. The leftover network can cause discomfort and chronic inflammation in the patient.

To bypass this issue, Scott developed a nanocarrier using self-assembled, filament-shaped nanomaterials, which are loaded with a drug or imaging agent. When crosslinked together, the filaments form a hydrogel network that is similar to structural tissue in the human body. After the filaments are injected into the body, the resulting hydrogel network functions as a drug depot that slowly degrades by breaking down into spherical nanomaterials called micelles, which are programmed to travel to specific targets. Because the network morphs into the drug-delivery system, nothing is less behind to cause inflammation.

"All of the material holds the drug and then delivers the drug," Scott explained. "It degrades in a controlled fashion, resulting in nanomaterials that are of equal shape and size. If we load a drug into the filaments, the micelles take the drug and leave with it."

After testing the system both in vitro and in vivo in an animal model, Scott's team demonstrated they could administer a subcutaneous injection that slowly delivered nanomaterials to cells in lymph nodes for over a month in a controlled fashion.

Scott said the system can be used for other nanostructures in addition to micelles. For example, the system could include vesicle-shaped nanoparticles, such as liposomes or polymersomes, that have drugs, proteins, or antibodies trapped inside. Different vesicles could carry different drugs and release them at different rates once inside the body.

"Next we are looking for ways to tailor the system to the needs of specific diseases and therapies," Scott said. "We're currently working to find ways to deliver chemotherapeutics and vaccines. Chemotherapy usually requires the delivery of multiple toxic drugs at high concentrations, and we could deliver all of these drugs in one injection at much lower dosages. For immunization, these injectable hydrogels could be administered like standard vaccines, but stimulate specific cells of the immune system for longer, controlled periods of time and potentially avoid the need for boosters."

References :
  1. Nicholas B. Karabin, Sean Allen et al. Sustained Micellar Delivery via Inducible Transitions in Nanostructure Morphology, Nature Communications doi:10.1038/s41467-018-03001-9

Source: Eurekalert

Citations   close


News A-Z
What's New on Medindia
Test Your Knowledge on Sugar Intake and Oral Health
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
View all
Recommended Reading
News Archive
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Healthy Living Drugs Banned in India 

Most Popular on Medindia

Sanatogen Drug - Food Interactions Pregnancy Confirmation Calculator Nutam (400mg) (Piracetam) Indian Medical Journals Accident and Trauma Care Turmeric Powder - Health Benefits, Uses & Side Effects Blood - Sugar Chart The Essence of Yoga A-Z Drug Brands in India
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use

Injecting Nanocarriers may Release Drugs in The Body for Months Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests